Home > CRO Services > AAV Services > AAV packaging (research-grade)

AAV packaging (research-grade)

Adeno-associated virus (AAV) is a  non-pathogenic single-stranded DNA virus. As one of the most important tools for gene therapy, recombinant adeno-associated virus (rAAV) can carry GOI to a variety of dividing and non-dividing cells showing long-term gene expression with low cellular immune response. Beside, the differences in capsid structure mediate the interaction of the AAV serotypes with different host cell receptors, leading to alternative tissue tropisms, which shows a great prospect in gene therapy research. In recent years, the FDA has approved numerous gene therapies delivered by rAAV, showing no serious vector-related adverse effects.

Interested in our AAV services?   Contact us for a free consultation or Request for a Quote.

AAV Packaging Services

PackGene provides multiple AAV packaging services according to customers’ requests or solutions. The serotypes covering  AAV1, 2, 3, 4, 5, 6, 7, 8, 9, rh10, PHP.B, PHP.eB, PHP.S, AAVDJ, retro, 7m8, etc.  We produce customized rAAV packaging by the Triple-plasmids-transfection in adherent 293 cells.

Our Superiority

Speed: PackGene’s proprietary technology on rAAV packaging is the major reason for our high quality and processing speed. We are committed to deliver requested amount of AAVs in the highest quality within 12-15 business days (If only the genes expressed in rAAV vector do not affect the AAV production too much), or we will give 5% of delayed order sum as credit which can used for the future orders.

Quality:The AAV genome copies is quantified via SYBR qPCR with ATCC Ref AAV for titer calibration, and the purity is determined by Coomassie-Blue staining. We deliver Guaranteed quantity of AAV, and in most case more than that, since we produce excessive scales to keep the Guaranteed promise. Besides, we also guarantee the endotoxin level of the AAV preps lower than 10 EU/ml.

Price for AAV packaging services

*The indicated titers are guaranteed except when the insert exceeds the packaging capacity (4.7 kb) or if you choose to provide us with your own modified rep/cap plasmid or helper plasmid.

AAV serotype Guaranteed yield (GC/VG)* LIST PRICE LEAD TIME
Normal-yield AAV serotype 2E+12 GC $1,494 12-15 BDs
5E+12 GC $1,839
1E+13 GC $2,989
2E+13 GC $5,289
5E+13 GC $9,889
1E+14 GC $14,489
2E+14 GC $21,389 18-24 BDs
5E+14 GC $46,689
1E+15 GC $92,689
2E+15 GC $185,378
 Low yield AAV serotype (AAV2, AAV4, AAV6) 2E+12 GC $1,839 12-15 BDs
5E+12 GC $2,989
1E+13 GC $5,289
2E+13 GC $9,889
5E+13 GC $14,489
1E+14 GC $21,389 18-24 BDs
2E+14 GC $37,489
4E+14 GC $58,189
Shipping Price Reference
Fedex Overnight Priority with Dry-ice is the default method for destination of U.S. and Canada. Fedex International Priority is the default method for oversea shipment. Please select the shipping destination below.
US/Canda Oversea
Shipping Fee (Frozen w/Dry-Ice) $80 $350

 

Notice: If AAV serotypes you desire for package are currently under patents, and your application is for commercial use or clinical trials. We advise that you contact the patent owner to obtain authorization beforehand.

AAV In Vivo Delivery & Experiment Design

 For target tissues with few references, it is recommended that researchers determine the most ideal serotype through pre-experimental tests, which will also be one of the heat innovations. 

Pre-experimental design can be conducted as below:

1.Serotype Selection: If you are not sure which AAV serotype is most suitable for your study, you can try more than three different fluorescent AAV serotypes for a pre-infection experiment.

  1. Gradient Dilution Infection: Due to the length and expression differences of each gene, it is strongly recommended to conduct gradient test of 3-4 injection doses of AAV expressing the target gene before the formal experiment, and increase by 3 times in turn according to the minimum requirements (e.g., 1E+11GC, 3E+11GC, 9E+11GC in gradient dilutions).

3.Experimental Control: Set a GFP positive control with the same serum type and the same promoter.

4.Detection Time: Usually the expression can be detected 3~4 weeks after injection, and it is recommended to do it after 4 weeks or more.

AAV in vitro infection

  • For cells cultured in vitro, AAV-DJ and AAV6 are common choices. AAV-DJ can infect more than 80% of cells under conventional culture, and AAV6 has the strongest ability to infect blood-derived cells.
  • It is strongly recommended that the gradient infection test (at least 3-4 gradient dilutions, such as MOI=1×10^3,MOI=1×10^4,MOI=1×10^5, and MOI=1×10^6) should be performed for the first use of AAVs and no cytotoxicity is a basic requirement for this kind of experiments.
  • Detection Time: Usually 2-7 days after infection.

Fast Service Ordering

SKU Description Price Lead Time Quantity Action
AAV-HBV-001-50 AAV8 [HBV-D,ayw],≥1E+13 GC/mL,50ul
AAV-HBV-001-100 AAV8 [ssAAV-HBV-D-AYW 1.3],≥1E+13 GC/mL,100ul
AAV-HBV-001-500 AAV8 [HBV-D,ayw],≥1E+13 GC/mL,500ul
AAV-HBV-002-50 AAV8 [HBV-C,adr],≥1E+13 GC/mL,50ul
AAV-HBV-002-100 AAV8 [HBV-C,adr],≥1E+13 GC/mL,100ul
AAV-HBV-002-500 AAV8 [HBV-C,adr],≥1E+13 GC/mL,500ul
AAV-HBV-003-50 AAV8 [HBV-C, Replication Defective],≥1E+13 GC/mL,50ul
AAV-HBV-003-100 AAV8 [HBV-C, Replication Defective],≥1E+13 GC/mL,100ul
AAV-HBV-003-500 AAV8 [HBV-C, Replication Defective],≥1E+13 GC/mL,500ul
AAV-HBV-004-50 AAV8 [HBV-B, adw],≥1E+13 GC/mL,50ul

Brochure download

PDF File. Right click & choose Save as to download.

General inquiry
  • Fast Service inquiry
  • Service inquiry
  • New fast service information
Technical support
  • Fast Service selection
  • Application & solution
  • Troubleshooting
Request a quote
  • Customization service
  • Tailored services
  • Pricing inquiry